Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-25 @ 4:07 AM
NCT ID:
NCT01784120
Eligibility Criteria:
Inclusion Criteria:
* 18 years of age or older adult women
* Instrumentation measurable lesions with histologically confirmed advanced (recurrent or metastatic) breast cancer
* ECOG 0-2
* Advanced breast cancer in the past, patients who did not receive chemotherapy
* Recurrence if adjuvant chemotherapy and adjuvant chemotherapy in the past for more than 6 months until the patient
* life expectancy more than 3 months
* Agree in writing before the party to participate in a clinical trial to patients
Exclusion Criteria:
* immunohistochemical staining 3 + or FISH positive anti-HER 2 therapy patients
* Severe infections requiring antibiotic therapy
* Clinically significant heart disease
* Pregnant or lactating woman
* Uncontrolled symptoms in the central nervous system (CNS) metastases
* Patients diagnosed with malignant tumors of other organs
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01784120
Study Brief:
Protocol Section:
NCT01784120